Legal Digest: Pharmaceutical Antitrust Disputes (Overview of Cases in 2019)
The new review of the most notable antitrust disputes in Life Sciences in Russia and CIS.
The new review of the most notable antitrust disputes in Life Sciences in Russia and CIS.
On October 18, 2018 new wording of the Rules of state registration and re-registration of maximum sale prices established by drug manufacturers for those drugs, that are included in the vital and essential drugs list (the Rules and the Drugs correspondingly) has been enacted with the amendments introduced by the Russian Government Decree of 08.10.2018 No. 1207 On amendments to the Russian Government Decree of October, 29 2010 No. 865 and of September, 15 2015 No. 979 (the Decree).
Presidium of the FAS Russia in its Clarification dated 21.02.2018 No. 13 On trade secrets information in the process of investigation of the case on violation of antimonopoly legislation, verification for abidance of antimonopoly legislation, state control for economic concentration (Clarification) notes that such information for which information owner doesn’t establish commercial secrecy regime according to Commercial secret law, isn’t protected by law.
On December 13, 2017, the Moscow Arbitrazh Court rendered decision in case No. A40-159212/17 in which KYB Corporation appealed against the warning letter of FAS Russia (hereinafter ─ FAS) regarding the violation of the antitrust legislation by struggling against parallel import.
The book discusses key aspects of Russian business law, providing an overview of the legislation: corporate, employment, foreign investment, antimonopoly law, litigation, arbitration and tax, as well as concentrating on practical areas of the law and analyzing recent findings from court cases. Along with descriptions of the major fields within Russian business law authors of the book emphasize the legislative regulation of specific business areas, including mining, banking and insurance, telecommunication, pharmaceutical, construction, retail, and others.
The book is written by Lidings’ lawyers and published by Aspatore books, a Thomson Reuters.
The site uses cookie technology to ensure optimal performance, analyze usage and improve user experience. By continuing to use the site, you consent to the placement of cookies on your device on the terms set out in the Privacy Policy.
To ensure optimal performance, analyze usage and improve user experience, the website may use web analytics systems (including Yandex.Metrica), which may place cookies on your device.
By continuing to use the website, you agree to the use of these technologies and the placement of cookies. You can delete cookies from your device through your browser settings and you can block the placement of cookies, however, in doing so, some website features may not be available due to the engine's technological limitations.
You can find more information in the Privacy Policy.